Mutations in KCNE2 have been associated with congenital or drug-induced Long QT syndromes (LQT; Q9E, M54T)62–67, sinus bradycardia (Q9E, M54T)48 and sudden infant death syndrome (V14I)20,68. Here, KCNE2 is linked to Sinus bradycardia.